belongs to the
family (or RGTA). These agents are used for
(or corneal matrix repair therapy).
CACICOL® triggers REGENERATION of damaged tissues for ENHANCED HEALING and makes it possible to DELAY OR AVOID a more invasive surgical procedure.
CACICOL® is intended for the management of chronic corneal wound healing, such as persistent epithelial defects and persistent corneal dystrophies with associated pain.
CACICOL® should be used with a medical prescription.
This medical device CACICOL® is a regulated healthcare product which, in compliance with the relevant legislation, bears CE marking. The pharmaceutical company Théa has carried out scientific studies to develop CACICOL®.
Each box of CACICOL® contains 5 detachable and ready-to-use single-dose units. CACICOL® is a preservative-free solution and has to be stored at a room temperature (between 4°C and 25°C).
The recommended dosage regimen of CACICOL® is 1 TO 2 DROPS ONCE A WEEK.
YOUR OPHTHALMOLOGIST MAY ADJUST THIS DOSE.
The mechanism of action of Cacicol
Cacicol® acts as a scaffold. Its matrix structure permits the fixation and the protection of the components involved in the tissue regeneration process.